The aim of this project is to use the Gata1low mouse model to identify in detail the patho-biological mechanism that determines the mobilization of stem/progenitor cells and extramedullary hematopoiesis in primary myelofibrosis.
Start and end date
May 2023 - May 2028
Project Manager
prof Maria Zingarielloariello
Coordinating institution of the project
MSSM
Other institutions involved in the project
Anna Rita Franco Migliaccio, Lecce, Italy
John A. Stamatoyannopoulos, Altius Institute for Biomedical Sciences, Seattle, WA, USA
John Crispino, St. Jude Children's Research Hospital, Memphis, TN, USA
Ronald Hoffman, Icahn School of Medicine at Mount Sinai, New York, NY, USA
John Mascarenhas, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Ross Levine, Memorial Sloan Kettering Cancer Center New York, NY
Funding source(s).
National Cancer Institute CA108671-11-16 MPD Research Consortium, PI Ronald Hoffman